Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activation

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Charbaji, Nada ^a   Schäfer Korting, Monika ^a   Küchler, Sarah ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MORPHINE; MU OPIATE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MOUTH MUCOSA; ORAL MUCOSITIS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; WESTERN BLOTTING; WOUND CLOSURE; WOUND HEALING;

CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHINE; MOUTH MUCOSA; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84864979830     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042616     Document Type: Article

References (51)

1. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ, (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8: 33-39.
2. Silvermann S Jr, (2007) Diagnosis and management of oral mucositis. J Support Oncol 5: 13-21.
3. Sonis ST, (2007) Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol 5: 3-11.
4. Stone R, Fliedner MC, Smiet AC, (2005) Management of oral mucositis in patients with cancer. Eur J Oncol Nurs 9 Suppl 1: S24-32.
5. Stein C, (2003) Opioid receptors on peripheral sensory neurons. Adv Exp Med Biol 521: 69-76.
6. Stein C, Schafer M, Machelska H, (2003) Attacking pain at its source: new perspectives on opioids. Nat Med 9: 1003-1008.
7. Bigliardi PL, Bigliardi-Qi M, Buechner S, Rufli T, (1998) Expression of mu-opiate receptor in human epidermis and keratinocytes. J Invest Dermatol 111: 297-301.
8. Bigliardi-Qi M, Sumanovski LT, Buchner S, Rufli T, Bigliardi PL, (2004) Mu-opiate receptor and Beta-endorphin expression in nerve endings and keratinocytes in human skin. Dermatology 209: 183-189.
9. Rachinger-Adam B, Conzen P, Azad SC, (2011) Pharmacology of peripheral opioid receptors. Curr Opin Anaesthesiol 24: 408-413.
10. Stein C, (1993) Peripheral mechanisms of opioid analgesia. Anesth Analg 76: 182-191.
11. Schäfer M, Imai Y, Uhl GR, Stein C, (1995) Inflammation enhances peripheral mu-opioid receptor-mediated analgesia, but not mu-opioid receptor transcription in dorsal root ganglia. Eur J Pharmacol 279: 165-169.
12. Stein C, (1995) The control of pain in peripheral tissue by opioids. N Engl J Med 332: 1685-1690.
13. Stein C, Hassan AH, Przewlocki R, Gramsch C, Peter K, et al. (1990) Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci U S A 87: 5935-5939.
14. Cerchietti LC, Navigante AH, Bonomi MR, Zaderajko MA, Menendez PR, et al. (2002) Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 95: 2230-2236.
15. Flock P, (2003) Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain. J Pain Symptom Manage 25: 547-554.
16. LeBon B, Zeppetella G, Higginson IJ, (2009) Effectiveness of topical administration of opioids in palliative care: a systematic review. J Pain Symptom Manage 37: 913-917.
17. Platzer M, Likar R, Stein C, Beubler E, Sittl R, (2005) [Topical application of morphine gel in inflammatory mucosal and cutaneous lesions]. Schmerz 19: 296-301.
18. Poonawala T, Levay-Young BK, Hebbel RP, Gupta K, (2005) Opioids heal ischemic wounds in the rat. Wound Repair Regen 13: 165-174.
19. Küchler S, Wolf NB, Heilmann S, Weindl G, Helfmann J, et al. (2010) 3D-wound healing model: influence of morphine and solid lipid nanoparticles. J Biotechnol 148: 24-30.
20. Wolf NB, Küchler S, Radowski MR, Blaschke T, Kramer KD, et al. (2009) Influences of opioids and nanoparticles on in vitro wound healing models. Eur J Pharm Biopharm 73: 34-42.
21. Cerchietti LC, Navigante AH, Korte MW, Cohen AM, Quiroga PN, et al. (2003) Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: a pilot study. Pain 105: 265-273.
22. Gysler A, Lange K, Korting HC, Schäfer-Korting M, (1997) Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts. Pharm Res 14: 793-797.
23. O'Kane S, Ferguson MW, (1997) Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 29: 63-78.
24. Geback T, Schulz MM, Koumoutsakos P, Detmar M, (2009) TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 46: 265-274.
25. Mosmann T, (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
26. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, et al. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632.
27. Ferreira SH, Nakamura M, (1979) II- Prostaglandin hyperalgesia: the peripheral analgesic activity of morphine, enkephalins and opioid antagonists. Prostaglandins 18: 191-200.
28. Bigliardi PL, Tobin DJ, Gaveriaux-Ruff C, Bigliardi-Qi M, (2009) Opioids and the skin-where do we stand? Exp Dermatol 18: 424-430.
29. Rupniak HT, Rowlatt C, Lane EB, Steele JG, Trejdosiewicz LK, et al. (1985) Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck. J Natl Cancer Inst 75: 621-635.
30. Moharamzadeh K, Brook IM, Van Noort R, Scutt AM, Thornhill MH, (2007) Tissue-engineered oral mucosa: a review of the scientific literature. J Dent Res 86: 115-124.
31. Cheng B, Liu HW, Fu XB, Sheng ZY, Li JF, (2008) Coexistence and upregulation of three types of opioid receptors, mu, delta and kappa, in human hypertrophic scars. Br J Dermatol 158: 713-720.
32. Salemi S, Aeschlimann A, Reisch N, Jungel A, Gay RE, et al. (2005) Detection of kappa and delta opioid receptors in skin-outside the nervous system. Biochem Biophys Res Commun 338: 1012-1017.
33. Prather PL, Tsai AW, Law PY, (1994) Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells. J Pharmacol Exp Ther 270: 177-184.
34. Zadina JE, Harrison LM, Ge LJ, Kastin AJ, Chang SL, (1994) Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. J Pharmacol Exp Ther 270: 1086-1096.
35. Ohshima M, Sato M, Ishikawa M, Maeno M, Otsuka K, (2002) Physiologic levels of epidermal growth factor in saliva stimulate cell migration of an oral epithelial cell line, HO-1-N-1. Eur J Oral Sci 110: 130-136.
36. Pasi A, Qu BX, Steiner R, Senn HJ, Bar W, et al. (1991) Angiogenesis: modulation with opioids. Gen Pharmacol 22: 1077-1079.
37. Farooqui M, Li Y, Rogers T, Poonawala T, Griffin RJ, et al. (2007) COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 97: 1523-1531.
38. Bigliardi-Qi M, Gaveriaux-Ruff C, Zhou H, Hell C, Bady P, et al. (2006) Deletion of delta-opioid receptor in mice alters skin differentiation and delays wound healing. Differentiation 74: 174-185.
39. Massague J, (1998) TGF-beta signal transduction. Annu Rev Biochem 67: 753-791.
40. Massague J, Chen YG, (2000) Controlling TGF-beta signaling. Genes Dev 14: 627-644.
41. Yue J, Frey RS, Mulder KM, (1999) Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta. Oncogene 18: 2033-2037.
42. Hartsough MT, Mulder KM, (1995) Transforming growth factor beta activation of p44mapk in proliferating cultures of epithelial cells. J Biol Chem 270: 7117-7124.
43. Weston CR, Davis RJ, (2007) The JNK signal transduction pathway. Curr Opin Cell Biol 19: 142-149.
44. Zhang YE, (2009) Non-Smad pathways in TGF-beta signaling. Cell Res 19: 128-139.
45. Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, et al. (2001) MAP kinases. Chem Rev 101: 2449-2476.
46. Huang C, Jacobson K, Schaller MD, (2004) MAP kinases and cell migration. J Cell Sci 117: 4619-4628.
47. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, et al. (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22: 153-183.
48. Li W, Nadelman C, Henry G, Fan J, Muellenhoff M, et al. (2001) The p38-MAPK/SAPK pathway is required for human keratinocyte migration on dermal collagen. J Invest Dermatol 117: 1601-1611.
49. Moon SE, Bhagavathula N, Varani J, (2002) Keratinocyte stimulation of matrix metalloproteinase-1 production and proliferation in fibroblasts: regulation through mitogen-activated protein kinase signalling events. Br J Cancer 87: 457-464.
50. Ibrahim AS, El-Remessy AB, Matragoon S, Zhang W, Patel Y, et al. Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes 60: 1122-1133.
51. Estrada Y, Dong J, Ossowski L, (2009) Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. Pigment Cell Melanoma Res 22: 66-76.